Veoza is a medicine used to treat moderate to severe vasomotor symptoms (also referred to as hot flushes or night sweats) associated with menopause. Veoza contains the active substance fezolinetant.
Therapeutic Indication
### Therapeutic indication Veoza is indicated for the treatment of moderate to severe vasomotor symptoms (VMS) associated with menopause.
Therapeutic Area (MeSH)
ATC Code
G02CX06
ATC Item
fezolinetant
Pharmacotherapeutic Group
Other gynecologicals
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| fezolinetant | N/A | Fezolinetant |
EMA Name
Veoza
Medicine Name
Veoza
Aliases
N/ANo risk management plan link.
